Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

97 Hyperbaric Oxygenation Therapy KCE Reports 74
114. Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective
clinical trial of hyperbaric oxygen versus penicillin. Journal of the American Dental Association
(1939). 1985;111(1):49-54.
115. Mitton C, Hailey D. Health technology assessment and policy decisions on hyperbaric oxygen
treatment. International Journal of Technology Assessment in Health Care. 1999;15(4):661-70.
116. Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic leg ulcers: a
randomized double-blind study. Plast Reconstr Surg. 1994;93(4):829-33; discussion 34.
117. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence,
outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3):382-7.
118. Couch NP, David JK, Tilney NL, Crane C. Natural history of the leg amputee. Am J Surg.
1977;133(4):469-73.
119. Kihn RB, Warren R, Beebe GW. The "geriatric" amputee. Ann Surg. 1972;176(3):305-14.
120. Mandrup-Poulsen T, Jensen JS. Mortality after major amputation following gangrene of the
lower limb. Acta Orthop Scand. 1982;53(6):879-84.
121. Strauss MB. Hyperbaric oxygen as an intervention for managing wound hypoxia: Its role and
usefulness in diabetic foot wounds. Foot and Ankle International. 2005;26(1):15-8.
122. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in
diabetic patients in a multidisciplinary setting. Foot Ankle Int. 1995;16(7):388-94.
123. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals.
Diabetes Care. 1983;6(1):87-91.
124. Cianci P, Petrone G, Drager S, Lueders H, Lee H, Shapiro R. Salvage of the Problem Wound
and Potential Amputation with Wound Care and Adjunctive Hyperbaric Oxygen Therapy: An
Economic Analysis. Journal of Hyperbaric Medicine. 1988;3(3):127-41.
125. Borssen B, Lithner F. Amputations in diabetics and nondiabetics in Umea county 1971-1977.
Acta Med Scand Suppl. 1984;687:95-100.
126. Lindegard P, Jonsson B, Lithner F. Amputations in diabetic patients in Gotland and Umea
counties 1971-1980. Acta Med Scand Suppl. 1984;687:89-93.
127. Klamer TW, Towne JB, Bandyk DF, Bonner MJ. The influence of sepsis and ischemia on the
natural history of the diabetic foot. Am Surg. 1987;53(9):490-4.
128. Ciaravino ME, Friedell ML, Kammerlocher TC. Is hyperbaric oxygen a useful adjunct in the
management of problem lower extremity wounds? Annals of Vascular Surgery. 1996;10(6):558-
62.
129. LeDez KM. Anesthesiology and hyperbaric medicine. Canadian Journal of Anesthesia.
2002;49(1):1-4.
130. Fife CE, Buyukcakir C, Otto G, Sheffield P, Love T, Warriner Iii R. Factors influencing the
outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy. Wound
Repair and Regeneration. 2007;15(3):322-31.
131. Winnen B. Hyperbare Zuurstoftherapie in Belgische ziekenhuizen: te veel en toch niet genoeg?
: Katholieke Universiteit Leuven; 2001.
132. Vlayen J, Van De Water G, Camberlin C, Paulus D, Leys M, Ramaekers D, et al. Klinische
kwaliteitsindicatoren. Objective Elements - Communication (OEC). 2006. Brussel: Federaal
Kenniscentrum voor de gezondheidszorg (KCE) KCE reports 41A (D/2006/10.273/43)
133. Treweek S, James PB. A cost analysis of monoplace hyperbaric oxygen therapy with and
without recirculation. Journal of Wound Care. 2006;15(6):235-8.
134. Cleemput I, Crott R, Vrijens F, Huybrechts M, Van Wilder P, Ramaekers D. Voorlopige
richtlijnen voor farmaco-economisch onderzoek in België. Health Technology Assessment
(HTA). Federaal Kenniscentrum voor de gezondheidszorg (KCE); 2006. KCE reports 28A
(D2006/10.273/10)